Age‐associated changes in neuroimaging biomarkers in a non‐human primate model of cerebral amyloid angiopathy

Abstract

Background: Amyloid related imaging abnormalities (ARIA) have emerged as indicators of potentially serious side effects in therapeutics for Alzheimer's disease (AD).